BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25010090)

  • 1. Effects of uPA on mesangial matrix changes in the kidney of diabetic rats.
    Cheng H; Chen C; Wang S
    Ren Fail; 2014 Sep; 36(8):1322-7. PubMed ID: 25010090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
    J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of urokinase-type plasminogen activator (uPA) on cell proliferation and phenotypic transformation of rat mesangial cells induced by high glucose.
    Cheng H; Chen C; Wang S; Ding G; Shi M
    Diabetes Res Clin Pract; 2014 Mar; 103(3):489-95. PubMed ID: 24447806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy.
    Nicholas SB; Aguiniga E; Ren Y; Kim J; Wong J; Govindarajan N; Noda M; Wang W; Kawano Y; Collins A; Hsueh WA
    Kidney Int; 2005 Apr; 67(4):1297-307. PubMed ID: 15780082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of acupoint-embedment of medicated-thread and acupoint-injection on expression of cortical urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in rats with cerebral ischemia-reperfusion injury].
    Kong LH; Ye YW; Zhou H; Zhou HJ; Du YJ; Cui CX
    Zhen Ci Yan Jiu; 2010 Dec; 35(6):409-14. PubMed ID: 21375013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
    Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
    Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H
    J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
    Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of C-peptide on renal morphology in diabetic rats.
    Sun W; Gao X; Zhao X; Cui D; Xia Q
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):893-9. PubMed ID: 21106770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
    Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL
    J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high concentration of glucose alters the production of tPA, uPA and PAI-1 antigens from human mesangial cells.
    Tada H; Tsukamoto M; Ishii H; Isogai S
    Diabetes Res Clin Pract; 1994 May; 24(1):33-9. PubMed ID: 7924884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells.
    Hagège J; Peraldi MN; Rondeau E; Adida C; Delarue F; Medcalf R; Schleuning WD; Sraer JD
    Am J Pathol; 1992 Jul; 141(1):117-28. PubMed ID: 1632457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of plasminogen activator inhibitor 1 gene transfer into mesangial cells on Extracellular matrix accumulation].
    Yu Z; Chen X; Liao H; Ye Y; Fu B
    Zhonghua Nei Ke Za Zhi; 1999 Aug; 38(8):541-5. PubMed ID: 11798694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy.
    Dal Monte M; Cammalleri M; Pecci V; Carmosino M; Procino G; Pini A; De Rosa M; Pavone V; Svelto M; Bagnoli P
    J Cell Mol Med; 2019 Feb; 23(2):1034-1049. PubMed ID: 30426662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models.
    Hagiwara H; Kaizu K; Uriu K; Noguchi T; Takagi I; Qie YL; Seki T; Ariga T
    Thromb Res; 2003; 111(4-5):301-9. PubMed ID: 14693179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.